Page last updated: 2024-09-03

umifenovir and Esophageal Squamous Cell Carcinoma

umifenovir has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dong, Z; Jiang, Y; Kim, MO; Laster, KV; Li, X; Liu, K; Lu, X; Wang, D; Wei, Y; Yang, N; Yu, Y; Yuan, B; Zhao, L	1

Other Studies

1 other study(ies) available for umifenovir and Esophageal Squamous Cell Carcinoma

Article	Year
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase. eLife, 2022, 09-09, Volume: 11 Topics: Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Indoles; Protein Kinases; Sulfides	2022

Article

Year

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase.

eLife, 2022, 09-09, Volume: 11

Topics: Apoptosis; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Indoles; Protein Kinases; Sulfides

2022